New Copper and Rhenium Radiopharmaceuticals

该项目的目的是通过设计和制造新的铼和铜配位配合物，为癌症的治疗和癌症和其他疾病的成像提供新的金属基放射性药物。将使用各种策略来选择性地和特异性地将这些金属配合物靶向到体内所需的区域，以进行非侵入性成像和治疗应用。最有希望的候选药物将在合适的细胞中进行测试。

The aims of this project are to provide new metal-based radiopharmaceuticals for the treatment of cancer, and the imaging of cancer and other conditions through the design and engineering of new coordination complexes of rhenium and copper. Various strategies will be used to selectively and specifically target these metal complexes to the desired areas in vivo for non-invasive imaging and therapeutic applications. The most promising candidates will be tested in the appropriate cells.